Vaccine Development Process Maps

Rapid vaccine development

In 2023, The UK Vaccine Network decided to create a rapid human vaccine development map, to reflect the lessons learnt during the COVID-19 pandemic. The first stage of this was to provide a case study of based on the UK experience with the Oxford-AstraZeneca COVID-19 vaccine. This map complements the existing human and veterinary full process development maps. To access this map, visit the COVID-19 menu tab above.

Future examples of rapid vaccine development and a pathogen-agnostic rapid development map will appear here in the future.